We are live on
!
Find out more
GWM
Geneos Wealth Management Portfolio holdings
AUM
$4.31B
1-Year Est. Return
18.36%
This Fund
S&P 500
This Quarter
Est. Return
+5.22%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$1.5B
AUM Growth
+$219M
(+17%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
10.37%
Top 10 Holdings %
Top 10 Hldgs %
19.84%
Holding
2,472
New
220
Increased
918
Reduced
391
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Lunt US Factor Rotation ETF
FCTR
|
+$21.9M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$13.3M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$8.95M |
| 4 |
DALT
Anfield Diversified Alternatives ETF
DALT
|
+$6.31M |
| 5 |
Vanguard Health Care ETF
VHT
|
+$6.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LVHB
Innovator Lunt Low Vol/High Beta Tactical ETF
LVHB
|
+$26.2M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$8.08M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$5.49M |
| 4 |
Cisco
CSCO
|
+$5.24M |
| 5 |
Wells Fargo
WFC
|
+$5.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.53% |
| 2 | Energy | 6.29% |
| 3 | Industrials | 6.24% |
| 4 | Healthcare | 5.52% |
| 5 | Financials | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
W.P. Carey
WPC
$17.1B
| $9.12M | 0.61% |
144,851
-534
| -0.4% | -$34.4K |
|
|
AXDX
27
DELISTED
Accelerate Diagnostics
AXDX
| $8.92M | 0.59% |
38,887
+27,210
| +233% | +$6.02M |
|
28
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.35B
| $8.91M | 0.59% |
122,414
+6,531
| +6% | +$471K |
|
29
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.08B
| $8.9M | 0.59% |
295,813
+5,361
| +2% | +$155K |
|
30
ConocoPhillips
COP
$144B
| $8.59M | 0.57% |
110,961
+1,611
| +1% | +$116K |
|
31
Verizon
VZ
$200B
| $8.45M | 0.56% |
158,313
+5,205
| +3% | +$276K |
|
32
Chevron
CVX
$382B
| $8.27M | 0.55% |
67,580
+2,549
| +4% | +$309K |
|
33
iShares Core MSCI Emerging Markets ETF
IEMG
$145B
| $8.16M | 0.54% |
157,491
-22,048
| -12% | -$1.15M |
|
34
Amgen
AMGN
$213B
| $8.03M | 0.53% |
38,753
+616
| +2% | +$121K |
|
35
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
| $7.98M | 0.53% |
289,331
+100,262
| +53% | +$2.81M |
|
36
IBM
IBM
$214B
| $7.91M | 0.53% |
54,708
+133
| +0.2% | +$18.6K |
|
37
Duke Energy
DUK
$101B
| $7.85M | 0.52% |
98,141
+2,471
| +3% | +$200K |
|
38
Meta Platforms (Facebook)
META
$1.5T
| $7.85M | 0.52% |
47,734
+18,230
| +62% | +$3.3M |
|
39
State Street SPDR S&P Dividend ETF
SDY
$22.2B
| $7.51M | 0.5% |
76,688
-2,333
| -3% | -$226K |
|
40
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.07B
| $7.38M | 0.49% |
239,581
+24,595
| +11% | +$756K |
|
41
Procter & Gamble
PG
$336B
| $7.07M | 0.47% |
84,935
+1,794
| +2% | +$147K |
|
42
Hormel Foods
HRL
$14.3B
| $7.03M | 0.47% |
178,411
-467
| -0.3% | -$17.9K |
|
43
iShares Russell 2000 ETF
IWM
$79.7B
| $6.77M | 0.45% |
40,144
+16,179
| +68% | +$2.73M |
|
44
Marathon Petroleum
MPC
$91B
| $6.76M | 0.45% |
84,575
-6,846
| -7% | -$541K |
|
45
iShares Core S&P Total US Stock Market ETF
ITOT
$93.1B
| $6.63M | 0.44% |
99,442
+21,015
| +27% | +$1.38M |
|
46
Kimberly-Clark
KMB
$37.3B
| $6.6M | 0.44% |
58,047
-347
| -0.6% | -$38.9K |
|
47
iShares S&P 500 Growth ETF
IVW
$71.2B
| $6.58M | 0.44% |
148,568
-1,444
| -1% | -$62.1K |
|
|
48
Vanguard Health Care ETF
VHT
$18.6B
| $6.57M | 0.44% |
36,410
+35,856
| +6,472% | +$6.16M |
|
49
Vanguard Total Stock Market ETF
VTI
$652B
| $6.37M | 0.42% |
42,561
+6,933
| +19% | +$1.02M |
|
50
CVS Health
CVS
$138B
| $6.32M | 0.42% |
80,266
+66,648
| +489% | +$4.76M |
|
Similar funds
IUHSA
MYIA
CW
IWM
NEI
NHC
Geneos Wealth Management's Q3 2018 Portfolio in Review
As of Q3 2018, Geneos Wealth Management held 2,472 positions worth $1.5B, up 17% from $1.28B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Geneos Wealth Management deployed $156M of net new capital in Q3 2018, opening 220 new positions and adding to 918 existing holdings. Its largest new stake was First Trust Lunt US Factor Rotation ETF: 1,071,026 shares worth $22.2M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, up from 6.3% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was Innovator Lunt Low Vol/High Beta Tactical ETF, an estimated $26.2M trimmed.
- Geneos Wealth Management's largest Q3 2018 buy was First Trust Lunt US Factor Rotation ETF: 1,071,026 shares worth $22.2M.
- Geneos Wealth Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $13.3M increase.
- Geneos Wealth Management's biggest Q3 2018 reduction was Innovator Lunt Low Vol/High Beta Tactical ETF, cutting an estimated $26.2M.
- Geneos Wealth Management fully exited iShares Currency Hedged MSCI Eurozone ETF in Q3 2018, selling an estimated $2.34M.
- Geneos Wealth Management's ten largest holdings make up 20% of its $1.5B portfolio in Q3 2018.
- Geneos Wealth Management opened 220 new positions and closed 67 in Q3 2018.
- Geneos Wealth Management's portfolio value rose 17% quarter-over-quarter to $1.5B.
Based on Geneos Wealth Management's 13F filing for Q3 2018, filed 7 Sep 2021.